Background Percutaneous ventricular assist devices (pVAD) have been increasingly used to support haemodynamics during ...

EBR Systems, Inc., developer of the world's only left ventricular wireless cardiac pacing device for heart failure, today announced that management will be participating at the Piper Sandler 37 (th) ...

VenstraMedical announced that it secured an investment to accelerate the development of its percutaneous ventricular assist ...

VenstraMedical Secures Investment From Highcroft Capital to Advance Next-generation Cardiac Support Device ...

About VIVO ™ Catheter Precision’s VIVO (View Into Ventricular Onset), is a non-invasive 3D imaging system that enables physicians to identify the origin of ventricular arrhythmias pre-procedure, ...

Abstract: Crack segmentation can play a critical role in Structural Health Monitoring (SHM) by enabling accurate identification of crack size and location, which allows to monitor structural damages ...

MedStar Washington Hospital Center has reached a major milestone in cardiac care by completing more than 500 HeartMate 3 Left Ventricular Assist Device (LVAD) implantations. This cutting-edge ...

Medtronic (NYSE: MDT) today announced new data supporting its Aurora and OmniaSecure defibrillation technology offerings.

LVADs have been life-savers for decades and, for a number of years, hospitals had a choice of two devices - the HeartWare ...

Seastar Medical Holding Corporation ((ICU)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and ...

A mother's decade-long battle with prescription ADHD drugs left her with so much heart damage she suffered a heart attack, and needed to terminate a pregnancy to save her own life. Mandi Masterpole ...

The NyokAssist device, from China, had few adverse outcomes by 30 days. More devices—and more trials—are on the way.